 LEVEL OF EVIDENCE - B] We suggest use of
low-molecular-weight heparin over vitamin K antagonist therapy of 3-month duration to decrease postthrombotic syndrome. [GRADE - 2; LEVEL OF EVIDENCE - B] We suggest catheter-directed thrombolysis in patients with low bleeding risk with iliofemoral DVT of duration <14 days. [GRADE - 2; LEVEL OF EVIDENCE - B]
Guideline 8